GRI Bio, Inc.
GRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001824293
No open-market purchases or sales by GRI Bio, Inc. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $164.7K in total; no superinvestor holds it.
Holders of 5% or more of GRI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of GRI Bio, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Intracoastal Capital, LLC | 13G/A | 9.99%1.10M shares | 0.00 ppfrom 9.99% | Apr 7, 20253 filings | Feb 13, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on GRI Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 20264:43 PM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 9.99%1.10M shares | 0.00 ppfrom 9.99% | Dec 31, 2025 | SEC |
| Feb 10, 20262:10 PM ET | Lincoln Alternative Strategies LLC | 13G/A | 0.00%0 shares | −11.83 ppfrom 11.83%Below 5% | Dec 30, 2025 | SEC |
| Dec 29, 20254:54 PM ET | Lincoln Alternative Strategies LLC | 13G | 11.83%1.20M shares | New | Dec 12, 2025 | SEC |
| Dec 17, 20258:19 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 9.99%677.5K shares | +5.00 ppfrom 4.99% | Dec 11, 2025 | SEC |
| Apr 7, 20254:17 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%40.3K shares | NewBelow 5% | Apr 1, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell GRI Bio, Inc. shares.
No Form 144 notices for GRI Bio, Inc. are on file.